Literature DB >> 26852725

New antibiotic development: the need versus the costs.

Tobias Welte1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26852725     DOI： 10.1016/S1473-3099(16)00068-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  6 in total

1.  Pneumococcal Conjugate Vaccine--Equally Effective for Everyone?

Authors:  Tobias Welte
Journal:  Dtsch Arztebl Int       Date:  2016-03-04       Impact factor: 5.594

2.  Flavonoid-Decorated Nano-gold for Antimicrobial Therapy Against Gram-negative Bacteria Escherichia coli.

Authors:  Suvadra Das; Tanay Pramanik; Megha Jethwa; Partha Roy
Journal:  Appl Biochem Biotechnol       Date:  2021-03-13       Impact factor: 2.926

Review 3.  [Antibiotic Stewardship 2.0. Individualization of therapy].

Authors:  M W Pletz; E Tacconelli; T Welte
Journal:  Internist (Berl)       Date:  2017-07       Impact factor: 0.743

4.  Evaluating Antimicrobial Activity and Wound Healing Effect of Rod-Shaped Nanoparticles.

Authors:  Wafaa E Soliman; Heba S Elsewedy; Nancy S Younis; Pottathil Shinu; Lamis E Elsawy; Heba A Ramadan
Journal:  Polymers (Basel)       Date:  2022-06-28       Impact factor: 4.967

5.  Developing a hybrid antimicrobial resistance surveillance system in India: Needs & challenges.

Authors:  Jasmine Kaur; Arun Sharma; Ajay Singh Dhama; Harish Buttolia; V C Ohri; Kamini Walia; Amitesh Kumar Sharma; Koji Yahara; Rafi Ahmad; Harpreet Singh
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

6.  [Infectiology in intensive care medicine].

Authors:  T Welte; K-F Bodmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-04       Impact factor: 0.840
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.